IPS-Integrated Project Services, a provider of engineering, procurement, construction management, and validation (EPCMV) services in the life sciences sector, is expanding in the UK and US markets.
The US-based company announced its European expansion at the end of January, followed by its Texas expansion in April.
IPS has developed a unique EPCMV delivery model, and the company is looking to bring its benefits to more customers.
The Texas branch
"As a firm with a proven history of success on projects across the state, we are uniquely positioned to bring global resources and subject matter expertise to local pharmaceutical, aseptic, cell therapy, gene therapy, compounding pharmacy, medical devices, and research and development (R&D) sectors," said Patrick Bucklen, VP of IPS and Regional Leader now residing in Houston.
Bucklen brings decades of experience in delivering life sciences projects in the US and China.
Having worked at IPS for more than 25 years, he expressed enthusiasm about the company’s expansion into Texas. "Our ability to combine global expertise with local talent will drive design innovation and regulatory compliance in the evolving life sciences landscape," he said.
By investing in strategic growth in Texas, IPS is poised to contribute significantly to the region’s economic development
IPS has developed a unique EPCMV delivery model, which will provide clients in Texas with a comprehensive and flexible approach to support research and development and manufacturing facility scale-up.
This model ensures efficiency, cost-effectiveness, and quality throughout the project lifecycle, from initial concept to final validation, accelerating time-to-market for life-saving therapies.
IPS continues to seek out and find the best engineers, subject matter experts and architects to support growing needs in the state to augment our presence in Houston, Austin, and Dallas.
By investing in strategic growth in Texas, IPS is poised to contribute significantly to the region’s economic development while reinforcing its commitment to shaping the future of healthcare.
The Alderley Park branch
IPS’s new Alderley Park office is the company’s second in the UK following its office in Birmingham.
Alderley Park, known for its innovation hub, was an ideal location for the company. The Alderley Park area is just outside of Manchester.
The Glasshouse, a state-of-the-art facility, not only expands the physical footprint but becomes an incubator for creativity and collaboration, embodying IPS's commitment to innovation and excellence in project services.
Jim Stephanou, CEO of IPS, emphasised the significance of this milestone. He said: "Our journey reflects the power of people, innovation, and collaboration. In just eight years, IPS’s growth trajectory has been nothing short of extraordinary."
"Our second location in the UK is a testament to our commitment to providing exceptional services and deepening our client relationships," Stephanou concluded.
Alderley Park, known for its innovation hub, was an ideal location for the company
This strategic, new office location sets the stage for further advancements and reinforces IPS’ position in the European market.
The company is eager to contribute to the thriving community at Alderley Park, pushing the boundaries of what’s possible in the life sciences industry.
